Related Experiment Video
Updated: Aug 25, 2026

A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
Eighteen years of fair glycemic control preserves cardiac autonomic function in type 1 diabetes
Jakob R Larsen1, Hans Sjøholm, Tore J Berg
1Diabetes Research Center, Aker and Ulleval University Hospitals, and Department of Pediatrics, Ulleval University Hospital, Oslo, Norway. j.r.larsen@ioks.uio.no
Insights
Maintaining a mean HbA1c below 8.4% over 18 years preserves cardiac autonomic function in type 1 diabetes patients. Higher HbA1c levels are linked to impaired cardiac autonomic function and dysfunction.
Area of Science:
- Cardiology
- Endocrinology
- Diabetology
Background:
- Type 1 diabetes management requires long-term glycemic control.
- Cardiac autonomic neuropathy is a serious complication of diabetes.
- The impact of sustained glycemic control on cardiac autonomic function needs further investigation.
Purpose of the Study:
- To investigate the association between long-term mean HbA1c levels and cardiac autonomic function.
- To assess cardiac autonomic function in type 1 diabetes patients after 18 years of intensive insulin treatment.
Main Methods:
- A cohort of 39 type 1 diabetes patients was followed for 18 years with annual HbA1c measurements.
- Cardiac autonomic function was assessed at 18-year follow-up using heart rate variability (HRV) and standard autonomic function tests.
- Tests included deep breathing, Valsalva maneuver, tilt test, exercise ECG, and nocturnal heart rate monitoring.
Main Results:
- Patients with mean HbA1c <8.4% demonstrated significantly better cardiac autonomic function across all tested parameters compared to those with HbA1c ≥8.4%.
- Heart rate variability during deep breathing was 40% in the low HbA1c group versus 19.9% in the high HbA1c group (P=0.005).
- The low HbA1c group exhibited a higher heart rate increase during maximal exercise (P=0.001) and lower minimal nocturnal heart rate (P=0.039).
Conclusions:
- Sustained glycemic control, with a mean HbA1c below 8.4%, is associated with preserved cardiac autonomic function in type 1 diabetes.
- Elevated mean HbA1c (≥8.4%) over 18 years is linked to impaired cardiac autonomic function and dysfunction.
- Intensive insulin treatment aiming for lower HbA1c levels may protect against diabetic cardiac autonomic neuropathy.
Objective:
To study the association between 18 years of mean HbA(1c) and cardiac autonomic function in type 1 diabetic patients having used intensive insulin treatment.
Research Design And Methods:
A total of 39 patients with type 1 diabetes were followed during 18 years, and HbA(1c) was measured yearly. At 18 years follow-up heart rate variability (HRV) measurements were used to assess cardiac autonomic function. Standard cardiac autonomic tests during normal breathing, deep breathing, the Valsalva maneuver, and the tilt test were performed. Maximal heart rate increase during exercise electrocardiogram and minimal heart rate during sleep were also used to describe cardiac autonomic function.
Results:
We present the results for patients with mean HbA(1c) <8.4% (two lowest HbA(1c) tertiles) compared with those with HbA(1c) > or = 8.4% (highest HbA(1c) tertile). All of the cardiac autonomic tests were significantly different in the high- and the low-HbA(1c) groups, and the most favorable scores for all tests were seen in the low-HbA(1c) group. In the low-HbA(1c) group, the HRV was 40% during deep breathing, and in the high-HbA(1c) group, the HRV was 19.9% (P = 0.005). Minimal heart rate at night was significantly lower in the low-HbA(1c) groups than in the high-HbA(1c) group (P = 0.039). With maximal exercise, the increase in heart rate was significantly higher in the low-HbA(1c) group compared with the high-HbA(1c) group (P = 0.001).
Conclusions:
Mean HbA(1c) during 18 years was associated with cardiac autonomic function. Cardiac autonomic function was preserved with HbA(1c) <8.4%, whereas cardiac autonomic dysfunction was impaired in the group with HbA(1c) > or = 8.4%.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
